Onpattro (patisiran)

**Product type:** Human Prescription Drug

**Active ingredient:** PATISIRAN SODIUM

**Strength:** 2 mg/mL

**Dosage form:** Injection, Lipid Complex

**Route:** Intravenous

**Labeler:** Alnylam Pharmaceuticals, Inc.

**Marketing category:** NDA (NDA210922)

**Pharmacologic class:** Decreased RNA Integrity [PE], Increased Protein Breakdown [PE], RNA, Small Interfering [CS], Small Interfering RNA [EPC], Transthyretin-directed RNA Interaction [EPC]